Latest filing published 23 Jun 2026 for BridgeBio Pharma, Inc., €132k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Hannah A Valantine: trading record in brief
Hannah A Valantine appears in our data through filings on BridgeBio Pharma, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 22 June 2026 to 23 June 2026, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 23 June 2026 came the latest disclosure, a transaction for €132k in BridgeBio Pharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Hannah A Valantine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,196 shares@ US$68.57CommonSEC144:0001950047-26-006404
- 2,808 shares@ US$68.00CommonSEC144:0001950047-26-006349
2 of 2 declarations
